Roche
Reports highlight recent developments from Roche
Published in Lab Business Week, February 4th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Roche.
Report 1: Roche announced the initiation of the first Phase II study to evaluate R1626, an investigational polymerase inhibitor, for the treatment of chronic hepatitis C.
The drug has also been granted Fast Track designation by the U.S. Food and Drug Administration, a program designed to facilitate the development and to expedite the review of new drugs with the potential to help treat serious or life-threatening conditions.
R1626, which has been shown to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-02-04)
More Articles from Lab Business Week
- Biomedical Engineering
Research from Dr. Reddy's Laboratories Ltd. in the area of biomedical engineering published - Biotechnology
Research from Michael Smith Laboratories broadens understanding of biotechnology - Business Update
Charles River Laboratories' Endosafe-Pts completes journey to International Space Station - Generic Drugs
Mylan's levothyroxine sodium tablets USP approved as generic equivalent to Levothroid - Genetics & Genomics
Research data from Jackson Laboratory update understanding of genetics & genomics - Immunology
Research on immunology discussed by scientists at EIC Laboratories, Inc. - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
